Skip to content
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto® ‑ Worldwide
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto® ‑ Worldwide
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto® ‑ Worldwide
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto® ‑ Worldwide
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto® ‑ Worldwide
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto® ‑ Worldwide
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto® ‑ Worldwide
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Products & Pipeline
Binosto® ‑ Worldwide
Alkindi®
Efmody®
Miglustat Dipharma
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
Rare Diseases - Switzerland
Alkindi®
› Information for Healthcare Professionals
› Patient Information
Lysodren®
› Information for Healthcare Professionals
› Patient Information
Metopiron®
› Information for Healthcare Professionals
› Patient Information
Miglustat Dipharma®
› Information for Healthcare Professionals
› Patient Information
